Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vilin Bio Med Ltd

NSE: VILINBIO · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹51.25
Market cap
₹78.16 Cr
Revenue (annual)
₹42.26 Cr
Net profit (annual)
₹1.93 Cr
P/E (TTM)
40.5×Sector 47.3×
Promoter holding
56.65%-2.92% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:26 IST NSE
Other Announcement

Vilin Bio Med Other Announcement

Vilin Bio Med Limited submitted a non-applicability certificate for the Annual Secretarial Compliance Report. The company is exempt from Regulation 24A as an SME-listed entity.

17:37 IST NSE
Other Announcement

Vilin Bio Med Other Announcement

Vilin Bio Med Limited filed its annual SDD Compliance Certificate for the financial year ended March 31, 2026. The certification confirms full regulatory database compliance.